Résultats de la recherche - 24 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
(SARI) from December 2021 to July 2022 (Omicron-dominant period).MethodsIn both networks, 46 hospitals (13 countries) follow a similar test-negative case-control protocol. We defined complete primary ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
2021.MethodsForty-six participating hospitals across 14 countries follow a similar generic protocol using the test-negative case-control design. We defined complete primary series vaccination (PSV) as two doses of ...
Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020
post-acute consequences, in 28 days (baseline) up to 140 days, following the initial infection. METHODS: National mortality, COVID-19 screening, and hospital admission data were used to calculate DALY s based ...
European Antimicrobial Resistance Surveillance For Belgium (EARSBE, EARSBE-URI, EARSBE-AMR)- Data call 2022, including case and data definitions, and instructions for participating laboratories.
Number: r D/2023.14.440/24 Keywords: Acute care hospitals Antimicrobial resistance Bloodstream infection clinical laboratories multidrug resistance urinary tract infection Health Topics: Multidrug ...
Hepatitis of unknown aetiology in children- epidemiological overview of cases reported in Europe, 1 January to 16 June 2022.
Euro Surveill, Volume 27, Issue 31 (2022) Keywords: Child COVID-19 Europe Hepatitis A Hospitalization Humans SARS-CoV-2 Abstract: Following the report of an excess in paediatric cases of severe acute ...
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
(until 3 months post-booster) were assessed. Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) antibody levels were followed over time (until 28 days after the ...
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
admitted to hospital with seasonal hCoV infections by age group. Samples received from week 8, 2020, were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Findings: 2573 primary care ...
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Control point prevalence survey of health-care-associated infections in European acute care hospitals in 2011-12 to estimate the number of non- BSI s. We developed disease outcome models for five types of ...
The health and economic impact of acute gastroenteritis in Belgium, 2010-2014
Disability-Adjusted Life Years Gastroenteritis Abstract: Acute gastroenteritis (AGE) remains a common condition in both low- and high-income countries. In Belgium, however, there is currently a lack of information on ...